Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection
- PMID: 31632660
- PMCID: PMC6784803
- DOI: 10.1002/cld.827
Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection
Figures
Similar articles
-
Advances in Gut Microbiota of Viral Hepatitis Cirrhosis.Biomed Res Int. 2019 Nov 22;2019:9726786. doi: 10.1155/2019/9726786. eCollection 2019. Biomed Res Int. 2019. PMID: 31886272 Free PMC article. Review.
-
Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration.BMC Gastroenterol. 2017 Nov 28;17(1):125. doi: 10.1186/s12876-017-0683-9. BMC Gastroenterol. 2017. PMID: 29179682 Free PMC article.
-
Gut microbiota and host metabolism in liver cirrhosis.World J Gastroenterol. 2015 Nov 7;21(41):11597-608. doi: 10.3748/wjg.v21.i41.11597. World J Gastroenterol. 2015. PMID: 26556989 Free PMC article. Review.
-
Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.World J Gastroenterol. 2014 Dec 7;20(45):16795-810. doi: 10.3748/wjg.v20.i45.16795. World J Gastroenterol. 2014. PMID: 25492994 Free PMC article. Review.
-
Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.Clin Gastroenterol Hepatol. 2019 Mar;17(4):756-765.e3. doi: 10.1016/j.cgh.2018.07.022. Epub 2018 Jul 20. Clin Gastroenterol Hepatol. 2019. PMID: 30036646
Cited by
-
The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies.Microorganisms. 2023 Dec 17;11(12):2999. doi: 10.3390/microorganisms11122999. Microorganisms. 2023. PMID: 38138143 Free PMC article. Review.
-
Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.Hepat Med. 2023 Oct 4;15:151-164. doi: 10.2147/HMER.S385133. eCollection 2023. Hepat Med. 2023. PMID: 37814605 Free PMC article. Review.
-
Integrated bioinformatical and in vitro study on drug targets for liver cirrhosis based on unsupervised consensus clustering and immune cell infiltration.Front Pharmacol. 2023 Jan 4;13:909668. doi: 10.3389/fphar.2022.909668. eCollection 2022. Front Pharmacol. 2023. PMID: 36686655 Free PMC article.
-
The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases.Int J Mol Sci. 2023 Jan 12;24(2):1470. doi: 10.3390/ijms24021470. Int J Mol Sci. 2023. PMID: 36674986 Free PMC article. Review.
-
Hepatogenous diabetes: Knowledge, evidence, and skepticism.World J Hepatol. 2022 Jul 27;14(7):1291-1306. doi: 10.4254/wjh.v14.i7.1291. World J Hepatol. 2022. PMID: 36158904 Free PMC article. Review.
References
-
- Tandon P, Garcia‐Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008;28:26‐42. - PubMed
-
- Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute‐on‐chronic liver failure: Prevalence, characteristics and impact on prognosis. Gut 2018;67:1870‐1880. - PubMed
-
- Albillos A, Lario M, Alvarez‐Mon M. Cirrhosis‐associated immune dysfunction: Distinctive features and clinical relevance. J Hepatol 2014;61:1385‐1396. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
